189 related articles for article (PubMed ID: 6525307)
1. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
László A; Klujber L
Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
[TBL] [Abstract][Full Text] [Related]
3. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
[TBL] [Abstract][Full Text] [Related]
4. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
Ballard FJ; Tomas FM; Stern LM
Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
Elia M; Carter A; Bacon S; Winearls CG; Smith R
Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
[TBL] [Abstract][Full Text] [Related]
6. 3-methylhistidine excretion in myotonic dystrophy.
Griggs RC; Moxley RT; Forbes GB
Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
[TBL] [Abstract][Full Text] [Related]
7. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
Rennie MJ; Millward DJ
Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
[No Abstract] [Full Text] [Related]
8. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
[TBL] [Abstract][Full Text] [Related]
9. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
Warnes DM; Tomas FM; Ballard FJ
Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
[TBL] [Abstract][Full Text] [Related]
10. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
McKeran RO; Halliday D; Purkiss P
J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of 3-methylhistidine and creatinine by healthy Dutch children during day and night. The influence of age and sex.
Speek AJ; Thissen JT; Schrijver J
J Clin Chem Clin Biochem; 1986 Jul; 24(7):465-70. PubMed ID: 3734709
[TBL] [Abstract][Full Text] [Related]
12. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
Röthig HJ; Bernhardt W; Afting EG
Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
[TBL] [Abstract][Full Text] [Related]
13. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment.
Kawai H; Adachi K; Nishida Y; Inui T; Kimura C; Saito S
J Neurol; 1993; 240(3):181-6. PubMed ID: 8482992
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of urinary 3-methylhistidine excretion in infection by measurements of 1-methylhistidine and the creatinine ratios.
Sjölin J; Stjernström H; Henneberg S; Hambraeus L; Friman G
Am J Clin Nutr; 1989 Jan; 49(1):62-70. PubMed ID: 2912013
[TBL] [Abstract][Full Text] [Related]
15. Quantitative importance of non-skeletal-muscle N tau-methylhistidine and creatine in human urine.
Afting EG; Bernhardt W; Janzen RW; Röthig HJ
Biochem J; 1981 Nov; 200(2):449-52. PubMed ID: 7340846
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion.
Tomas FM; Ballard FJ; Pope LM
Clin Sci (Lond); 1979 Apr; 56(4):341-6. PubMed ID: 477219
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of Duchenne muscular dystrophy: failure of amniotic fluid and maternal serum N tau-methylhistidine analyses to detect affected fetuses.
Wassner SJ; Li JB; Ladda RL; Lorenz RP; Emery AE
Am J Obstet Gynecol; 1982 May; 143(2):216-9. PubMed ID: 7081334
[TBL] [Abstract][Full Text] [Related]
18. Urinary 3-methylhistidine derivative as indicator of nutrients intake in low-birth-weight infants.
Gil A; Faus MJ; Robles R; Pita ML; Sánchez-Pozo A; Linares MD; Sánchez-Medina F
Horm Metab Res; 1984 Dec; 16(12):667-70. PubMed ID: 6526369
[TBL] [Abstract][Full Text] [Related]
19. Effect of exercise on protein degradation: 3-methylhistidine and creatinine excretion.
Radha E; Bessman SP
Biochem Med; 1983 Feb; 29(1):96-100. PubMed ID: 6838503
[TBL] [Abstract][Full Text] [Related]
20. [Value of the determination of urinary 3-methylhistidine (3 MEHIS) in the evaluation of postoperative muscular catabolism].
François G; Blanc M; Blache JL; Granthil C; Rose F
Ann Anesthesiol Fr; 1981; 22(4):339-45. PubMed ID: 6119943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
